← Eichor
Study identifier: NCT05884723 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis

Condition: Liver Steatoses · Liver Metastasis Colon Cancer · NAFLD  ·  Sponsor: Anton Skaro

PhaseNA
Planned participants124
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Non-alcoholic fatty liver disease is becoming increasingly common in Canada and throughout the world. Fatty liver can increase the risks of perioperative complications for those who need liver surgery. A ketogenic diet is low in carbohydrates and can be very effective in reducing liver fat content. The purpose of this randomized control trial is to compare the effect of a short duration (4 week) preoperative ketogenic diet on operative and disease outcomes in patients undergoing liver surgery. One arm will be randomized to the ketogenic diet and the other will receive standard of care pre-operative dietary consultation.

This description comes directly from the study's public registry record.

Talk to the study team

Anton Skaro, MD PhD  ·  519-685-8500  ·  Anton.Skaro@lhsc.on.ca

Crystal Engelage, PhD  ·  519-685-8500  ·  Crystal.Engelage@lhsc.on.ca

Always discuss trial participation with your own doctor first.

Locations (1)

London Health Sciences Centre/Western UniversityLondon, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05884723